Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

BUY
$0.17 - $0.34 $1,842 - $3,684
10,836 Added 2.38%
465,703 $88,000
Q4 2021

Feb 11, 2022

SELL
$0.34 - $1.0 $7,163 - $21,069
-21,069 Reduced 4.43%
454,867 $159,000
Q3 2021

Nov 12, 2021

BUY
$0.96 - $1.62 $111,989 - $188,982
116,656 Added 32.47%
475,936 $456,000
Q2 2021

Aug 13, 2021

SELL
$1.09 - $1.49 $192,068 - $262,552
-176,210 Reduced 32.91%
359,280 $502,000
Q1 2021

May 12, 2021

BUY
$1.26 - $2.02 $154,865 - $248,276
122,909 Added 29.79%
535,490 $728,000
Q4 2020

Feb 12, 2021

BUY
$0.9 - $1.54 $45,981 - $78,678
51,090 Added 14.13%
412,581 $552,000
Q3 2020

Nov 13, 2020

BUY
$0.87 - $2.08 $14,566 - $34,825
16,743 Added 4.86%
361,491 $343,000
Q2 2020

Aug 13, 2020

BUY
$1.08 - $4.0 $164,447 - $609,064
152,266 Added 79.11%
344,748 $534,000
Q1 2020

May 14, 2020

BUY
$1.01 - $2.74 $1,021 - $2,770
1,011 Added 0.53%
192,482 $219,000
Q2 2019

Aug 14, 2019

SELL
$1.63 - $3.3 $147,265 - $298,145
-90,347 Reduced 32.06%
191,471 $329,000
Q1 2019

May 14, 2019

BUY
$2.95 - $4.16 $30,001 - $42,307
10,170 Added 3.74%
281,818 $918,000
Q4 2018

Feb 13, 2019

BUY
$2.97 - $4.52 $32,200 - $49,005
10,842 Added 4.16%
271,648 $844,000
Q3 2018

Nov 13, 2018

BUY
$4.13 - $6.84 $48,436 - $80,219
11,728 Added 4.71%
260,806 $1.12 Million
Q2 2018

Aug 14, 2018

BUY
$4.44 - $10.4 $1.11 Million - $2.59 Million
249,078 New
249,078 $1.63 Million

Others Institutions Holding CWBR

# of Institutions
1
Shares Held
1.14K
Call Options Held
0
Put Options Held
0

About CohBar, Inc.


  • Ticker CWBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,906,940
  • Market Cap $1.19M
  • Description
  • CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...
More about CWBR
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.